Ascendis Pharma A/S - Cash Flow | Stock Club

ASNDAscendis Pharma A/S$ --

Ascendis Pharma A/S

Name: Ascendis Pharma A/S（ASND） Cash Flow Statement
Creator: Stock Club
License: https://stock-club.net/en/rule

ASND

$ -

Review operating, investing, and financing cash flow trends alongside detailed breakdowns.

paymentsCash Flow (CF) Summary

Updated: 2026/06/30FY2026 Q2

Operating CF

286.3M EUR

YoY +4000.7%

Investing CF

-2.9M EUR

YoY +34.1%

Financing CF

-46.6M EUR

YoY -768.0%

Cash Flow Trend (5 Years)

Cash in goes right, cash out goes left.

Investing CF

Operating CF

Financing CF

2023–2025

2023Free CF -469.8M

Operating

Investing

Financing

-467.4M

+286.5M

+134.3M

2024Free CF -307.6M

Operating

Investing

Financing

-306.2M

+6.9M

+443.9M

2025Free CF +43.6M

Operating

Investing

Financing

+51.8M

-8.2M

+34.9M

351.4M

-110.6M

-417.6M

2021

61.7M

396.8M

-495.7M

2022

286.5M

134.3M

-467.4M

2023

6.9M

443.9M

-306.2M

2024

51.8M

34.9M

-8.2M

2025

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

-417.6M-110.6M-495.7M61.7M-467.4M286.5M-306.2M6.9M51.8M-8.2M0

20212022202320242025

waterfall_chartCash Flow Bridge (FY2025 Full Year)

Beginning / Ending

Increase

Decrease

800M600M400M200M0-200M

493.1M

OpenBeginning Cash

51.8M

Op.Operating CF

-8.2M

Inv.Investing CF

34.9M

Fin.Financing CF

44.1M

OtherOther

615.8M

CloseEnding Cash

Cash Flow Details

Unit: USD

Net Income from Continuing Operations

-219.03M

Depreciation and Amortization

17.00M

Depreciation and Amortization

17.00M

Stock-based Compensation

Other Non-cash Items

182.44M

Adjustments to Net Income

182.44M

Other Operating Activity

182.44M

Change in Working Capital

68.16M

Change in Account Receivables

14.97M

Change in Trade Receivables

14.97M

Change in Inventory

-5.69M

Change in Payables and Accrued Expenses

-9.96M

Other Working Capital Changes

68.84M

Cash Flow from Operating Activities

51.77M

Net Fixed Asset Activity

-8.15M

Net Investment Securities Activity

Other Investing Activity

Cash Flow from Investing Activities

-8.15M

Net Borrowings

-21.09M

Net Issuance / Repurchase of Stock

66.93M

Issuance of Capital Stock

83.64M

Total Dividends Paid

Net Dividends Paid

Treasury / Other Financing Activity

-10.95M

Cash Flow from Financing Activities

34.89M

Beginning Cash and Cash Equivalents

493.13M

Net Change in Cash and Cash Equivalents

122.65M

Net Change in Cash and Cash Equivalents

122.65M

Exchange Rate Changes

44.13M

Ending Cash and Cash Equivalents

615.78M

Free Cash Flow

43.62M

Item

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Net Income from Continuing Operations

Depreciation and Amortization

Stock-based Compensation

Other Non-cash Items

Adjustments to Net Income

Other Operating Activity

Change in Working Capital

Change in Account Receivables

Change in Trade Receivables

Change in Inventory

Change in Payables and Accrued Expenses

Other Working Capital Changes

Cash Flow from Operating Activities

-219.03M

17.00M

182.44M

68.16M

14.97M

-5.69M

-9.96M

68.84M

51.77M

Net Fixed Asset Activity

Net Investment Securities Activity

Other Investing Activity

Cash Flow from Investing Activities

-8.15M

Net Borrowings

Net Issuance / Repurchase of Stock

Issuance of Capital Stock

Total Dividends Paid

Net Dividends Paid

Treasury / Other Financing Activity

Cash Flow from Financing Activities

-21.09M

66.93M

83.64M

-10.95M

34.89M

Beginning Cash and Cash Equivalents

Net Change in Cash and Cash Equivalents

Exchange Rate Changes

Ending Cash and Cash Equivalents

Free Cash Flow

493.13M

122.65M

44.13M

615.78M

43.62M

Unlock Long-Term Cash Flow Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan